Tetracosactide

CAS No. 16960-16-0

Tetracosactide( —— )

Catalog No. M29730 CAS No. 16960-16-0

Tetracosactide (INN) is a synthetic peptide that is identical to the 24-amino acid segment (sequence: SYSMEHFRWGKPVGKKRRPVKVYP) at the N-terminal of adrenocorticotropic hormone.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 113 In Stock
10MG 183 In Stock
25MG 312 In Stock
50MG 440 In Stock
100MG 616 In Stock
200MG 830 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tetracosactide
  • Note
    Research use only, not for human use.
  • Brief Description
    Tetracosactide (INN) is a synthetic peptide that is identical to the 24-amino acid segment (sequence: SYSMEHFRWGKPVGKKRRPVKVYP) at the N-terminal of adrenocorticotropic hormone.
  • Description
    Tetracosactide (INN) is a synthetic peptide that is identical to the 24-amino acid segment (sequence: SYSMEHFRWGKPVGKKRRPVKVYP) at the N-terminal of adrenocorticotropic hormone.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    16960-16-0
  • Formula Weight
    2933.44
  • Molecular Formula
    C136H210N40O31S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : 100 mg/mL (34.09 mM)
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Fluorescein diphosph...

    Fluorescein diphosphate tetraammonium is a fluorescent dye and a fluorescent phosphatase substrate that is hydrolyzed into highly fluorescent fluorescein after interaction with phosphatases.

  • 20-Hydroxylucidenic ...

    20-Hydroxylucidenic acid E2 is a triterpenoid compound found in Ganoderma lucidum. It exhibits significant inhibitory effects on inflammation induced by TPA . Additionally, 20-Hydroxylucidenic acid E2 can suppress the expression of EBV early antigen induced by TPA , with a IC50 of 290 mol ratio/32 pmol TPA (meaning that when the molar concentration of this compound is 290 times that of 32 pmol of TPA, it can inhibit 50% of EBV early antigen expression). Therefore, 20-Hydroxylucidenic acid E2 has potential applications in anti-inflammatory and anticancer research.

  • Laprafylline

    Laprafylline is a xanthine compound with inhibitory effects on bronchoconstriction in vivo and antitumor activity.